Stay updated with breaking news from Roger Adsett. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Insmed (NASDAQ:INSM – Get Rating) was downgraded by equities researchers at StockNews.com from a “hold” rating to a “sell” rating in a research report issued on Thursday. INSM has been the subject of a number of other reports. HC Wainwright reaffirmed a “buy” rating and issued a $52.00 price target on shares of Insmed in […]
Shares of Insmed Incorporated (NASDAQ:INSM – Get Rating) have earned an average rating of “Buy” from the eleven analysts that are presently covering the company, Marketbeat reports. Eleven equities research analysts have rated the stock with a buy rating. The average 1-year price target among analysts that have issued a report on the stock in […]
Insmed Incorporated (NASDAQ:INSM – Get Rating) COO Roger Adsett sold 8,981 shares of the company’s stock in a transaction on Tuesday, June 13th. The shares were sold at an average price of $19.32, for a total transaction of $173,512.92. Following the completion of the sale, the chief operating officer now owns 151,352 shares of the […]
Neo Ivy Capital Management lowered its stake in shares of Insmed Incorporated (NASDAQ:INSM – Get Rating) by 32.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 5,790 shares of the biopharmaceutical company’s stock after selling 2,841 shares during the quarter. Neo Ivy Capital Management’s […]
StockNews.com lowered shares of Insmed (NASDAQ:INSM – Get Rating) from a hold rating to a sell rating in a research note published on Thursday morning. A number of other equities research analysts have also recently commented on INSM. Barclays dropped their target price on Insmed from $37.00 to $35.00 and set an overweight rating on […]